Anti-VEGFR2 monoclonal antibody
Ramucirumab (Specialist drug)
Brand names: Cyramza
Adult dose
Dose: Specialist initiation only — refer to BNF/SmPC
Route: IV
Frequency: every 2-3 weeks
Clinical pearls
- Advanced gastric/colorectal/NSCLC (per indication)
- Specialist oncology
Contraindications
- Severe hypertension
- GI perforation history
- Pregnancy
- Severe hepatic impairment
Side effects
- Hypertension
- Bleeding
- Arterial thrombotic events
- GI perforation
- Impaired wound healing
- Proteinuria
- Infusion reactions
Interactions
- Anticoagulants
- NSAIDs (bleeding)
- Live vaccines
Monitoring
- BP
- Urinalysis
- FBC
Reference: BNF; NICE TA378/TA439; SmPC; https://bnf.nice.org.uk/drugs/ramucirumab-specialist-drug/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
- Vancomycin Dosing Calculator · Drug Dosing
- Phenytoin Correction for Albumin / Renal Failure · Drug Dosing
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Tisdale Risk Score for QT Prolongation · Arrhythmia
- Bazett Corrected QT Interval (QTc) Calculator · Arrhythmia
- DAPT Score for Dual Antiplatelet Therapy Duration · Antiplatelet Therapy